Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

A board certified hematologist, Dr. Hochman treats patients with acute leukemia, myelodysplastic neoplasms and other myeloid malignancies. Dr. Hochman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. Dr. Hochman received his Medical Degree from Duke University School of Medicine in Durham, North Carolina. He completed his residency at University of Washington Affiliated Hospitals in Seattle, Washington. He completed his fellowship in hematology at Johns Hopkins University School of Medicine in Baltimore, Maryland, where he served as Chief Fellow in his final year. Dr. Hochman's research focuses on developing novel therapeutic strategies for treatment of myeloid malignancies, including new drugs and drug combinations. He is also studying the use of new technologies to better predict treatment outcomes and assess measurable residual disease among clonal myeloid disorders.